ADVERTISEMENT
ADVERTISEMENT

OncoLink

Thank you so much for publishing an article on OncoLink [F. Hoke, The Scientist, April 3, 1995, page 1]. I thought it was a good, balanced report. I believe that a quality future for OncoLink, or OncoLink by another name, will happen only if discussion concerning OncoLink has a good media forum. Thank you for providing such a forum. I don't believe that the present editors of OncoLink understand the dynamics necessary to keep OncoLink current and responsive to patients' needs. They envisioned

Linda Yarger
Thank you so much for publishing an article on OncoLink [F. Hoke, The Scientist, April 3, 1995, page 1]. I thought it was a good, balanced report.

I believe that a quality future for OncoLink, or OncoLink by another name, will happen only if discussion concerning OncoLink has a good media forum. Thank you for providing such a forum.

I don't believe that the present editors of OncoLink understand the dynamics necessary to keep OncoLink current and responsive to patients' needs. They envisioned themselves primarily as editors or reviewers. Essentially this is a passive role. OncoLink attained its former status because Loren Buhle did not operate in a passive role. By reading Internet Usenet and mailing/discussion lists and by participating in the CompuServe cancer forum, he stayed informed about patients' most urgent concerns. A concept of what material is needed and the dedication to find such material...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
ADVERTISEMENT